Last reviewed · How we verify

RTX treatment — Competitive Intelligence Brief

RTX treatment (RTX treatment) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Oncology, Neurosurgery.

marketed Oncology, Neurosurgery Small molecule Live · refreshed every 30 min

Target snapshot

RTX treatment (RTX treatment) — Xuanwu Hospital, Beijing. RTX is a robotic stereotactic radiosurgery system that delivers highly focused radiation beams to target intracranial lesions with sub-millimeter precision.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
RTX treatment TARGET RTX treatment Xuanwu Hospital, Beijing marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). RTX treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/rtx-treatment. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: